RENAL IMPAIRMENT
Clinical trials for RENAL IMPAIRMENT explained in plain language.
Never miss a new study
Get alerted when new RENAL IMPAIRMENT trials appear
Sign up with your email to follow new studies for RENAL IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart-Kidney drug trial halted early – what happened?
Disease control TerminatedThis early-stage trial tested an experimental drug called AZD3427 in 10 people with heart failure and reduced kidney function. The goal was to see if the drug could improve blood flow to the kidneys, measured with a special PET scan. However, the study was terminated early, so we…
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New Heart-Kidney combo drug tested in tiny study
Disease control TerminatedThis early study tested a new drug called AZD5462 added to the standard medicine dapagliflozin in people with heart failure and moderate kidney disease. Only 8 participants were enrolled before the study was stopped. The goal was to see if the combination is safe and affects how …
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Insulin showdown: toujeo vs tresiba for diabetics with kidney disease
Disease control TerminatedThis study compared two long-acting insulins, Toujeo and Tresiba, in people with type 2 diabetes who also have kidney problems and had never used insulin before. The goal was to see which one controls blood sugar better and causes fewer low blood sugar events. The trial was stopp…
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 14:43 UTC